Acrivon Therapeutics Inc

ACRV USD0.001
Create an alert
Sell$2.20
Buy$2.38
$0.01 (0.45%)
Last updated today at
Back to dashboard

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
18 August 2026
Peter Blume-JensenChairman/CEO
Sell
Tax related
1,229$2.01$2,470.292,244,088
18 August 2026
Peter Blume-JensenChairman/CEO
Sell
Tax related
484$2.01$972.84385,859
18 August 2026
Eric J DevroeCOO
Sell
Tax related
604$2.01$1,214.04146,349
18 August 2026
Mary-Alice MillerChief Legal/Compliance Officer
Sell
Tax related
185$2.01$371.8582,009
18 August 2026
Erick GamelinChief Level Officer
Sell
Tax related
400$2.01$804.0052,592
18 August 2026
Katharine (Katie) PetersonChief Accounting Officer
Sell
Tax related
101$2.01$203.0118,033
4 August 2026
Adam D LevyCFO
Sell
Tax related
1,142$1.57$1,792.9466,008
21 July 2026
Mary-Alice MillerChief Legal/Compliance Officer
Sell
Tax related
573$1.76$1,008.4882,194
21 May 2026
Peter Blume-JensenChairman/CEO
Sell
Tax related
13,729$1.79$24,574.912,245,317
14 May 2026
Peter Blume-JensenChairman/CEO
Sell
Tax related
1,253$1.92$2,405.762,078,951

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
22 April 2026
RA CAPITAL MANAGEMENT LPInvestment Management Company
Buy
Regular purchase transaction
3,888,888$1.80$6,999,998.4011,803,094
14 November 2025
Peter Blume-JensenChairman/CEO
Sell
Tax related
59,765$2.24$133,873.602,066,675
14 January 2026
Peter Blume-JensenChairman/CEO
Buy
Regular purchase transaction
49,000$1.68$82,124.002,095,771
21 November 2025
Peter Blume-JensenChairman/CEO
Sell
Tax related
19,904$2.30$45,779.202,046,771
21 May 2026
Peter Blume-JensenChairman/CEO
Sell
Tax related
13,729$1.79$24,574.912,245,317

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.